Voltaren Forte gel (diclofenac diethylamine 23.2 mg/g)

Voltaren Forte is the topical diclofenac gel shown on the tube: diclofenac diethylamine 23.2 mg per gram (marketed as Voltaren Forte 2.32% gel). This formulation and strength are sold in many European/Nordic markets as a topical NSAID for local relief of pain and inflammation (joints, muscles, sprains, etc.). (subra.bg)

The Voltaren brand and the diclofenac medicine trace back to the Swiss pharmaceutical group Ciba‑Geigy (patent and original development of diclofenac), later incorporated into Novartis; Voltaren as a brand then moved through Novartis/GSK consumer health arrangements. (en.wikipedia.org)

In recent corporate structure, Voltaren is part of the consumer‑health portfolio now managed by Haleon plc (the consumer‑health spin‑off from GSK/Pfizer), a UK‑headquartered multinational which owns and markets Voltaren as an OTC/topical pain brand in many markets. Manufacturing and marketing responsibilities differ by country: marketing authorization and supply arrangements have included GlaxoSmithKline Dungarvan Limited (Ireland) and regional manufacturing entities such as Haleon Germany GmbH — therefore production is carried out in multiple locations depending on the market and regulatory approvals. (en.wikipedia.org)

Practical notes: the tube in the provided photo contains multilingual labelling (e.g., the word "hlaup" for gel), which aligns with packaging produced for Nordic/Baltic markets; manufacturers and the stated Marketing Authorization Holder can vary by country, so the supply site for any single retail pack should be confirmed from the box or local regulator if a precise factory origin is required. (subra.bg)